Compare ZDAI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZDAI | TRIB |
|---|---|---|
| Founded | 2022 | 1992 |
| Country | Hong Kong | Ireland |
| Employees | 33 | N/A |
| Industry | General Bldg Contractors - Nonresidential Bldgs | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 14.2M |
| IPO Year | N/A | 1996 |
| Metric | ZDAI | TRIB |
|---|---|---|
| Price | $1.90 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 339.4K | ★ 1.4M |
| Earning Date | 05-15-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.31 |
| 52 Week High | $11.48 | $3.44 |
| Indicator | ZDAI | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 35.21 | 36.35 |
| Support Level | $1.71 | $0.31 |
| Resistance Level | $2.04 | $0.41 |
| Average True Range (ATR) | 0.18 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 33.33 | 35.14 |
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.